FI51694C - Menetelmä uusien farmaseuttisesti arvokkaiden piperatsiinien ja niiden happoadditiosuolojen valmistamiseksi - Google Patents

Menetelmä uusien farmaseuttisesti arvokkaiden piperatsiinien ja niiden happoadditiosuolojen valmistamiseksi

Info

Publication number
FI51694C
FI51694C FI670729A FI72967A FI51694C FI 51694 C FI51694 C FI 51694C FI 670729 A FI670729 A FI 670729A FI 72967 A FI72967 A FI 72967A FI 51694 C FI51694 C FI 51694C
Authority
FI
Finland
Prior art keywords
piperazines
preparation
acid addition
addition salts
novel pharmaceutically
Prior art date
Application number
FI670729A
Other languages
English (en)
Swedish (sv)
Other versions
FI51694B (fi
Inventor
Willem Jacob Van Der Burg
Jacques Delobelle
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of FI51694B publication Critical patent/FI51694B/fi
Application granted granted Critical
Publication of FI51694C publication Critical patent/FI51694C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI670729A 1966-03-12 1967-03-10 Menetelmä uusien farmaseuttisesti arvokkaiden piperatsiinien ja niiden happoadditiosuolojen valmistamiseksi FI51694C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL6603256A NL6603256A (fi) 1966-03-12 1966-03-12

Publications (2)

Publication Number Publication Date
FI51694B FI51694B (fi) 1976-11-30
FI51694C true FI51694C (fi) 1977-03-10

Family

ID=19795968

Family Applications (1)

Application Number Title Priority Date Filing Date
FI670729A FI51694C (fi) 1966-03-12 1967-03-10 Menetelmä uusien farmaseuttisesti arvokkaiden piperatsiinien ja niiden happoadditiosuolojen valmistamiseksi

Country Status (13)

Country Link
US (1) US3534041A (fi)
BE (1) BE695304A (fi)
BR (1) BR6787719D0 (fi)
CH (1) CH501647A (fi)
DE (2) DE1795836C2 (fi)
DK (1) DK124824B (fi)
ES (1) ES337526A1 (fi)
FI (1) FI51694C (fi)
FR (1) FR6764M (fi)
GB (1) GB1173783A (fi)
GR (1) GR37262B (fi)
NL (2) NL6603256A (fi)
SE (1) SE331999B (fi)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3714148A (en) * 1968-10-15 1973-01-30 Sumitomo Chemical Co Process for preparing dibenzazocine derivatives and salts thereof
NL179906C (nl) * 1974-02-09 1986-12-01 Akzo Nv Werkwijze voor het bereiden van 1,2,3,4,10,14b-hexahydrodibenzo(c,f)pyrazino (1,2-a)azepine derivaten.
US4217452A (en) * 1974-02-09 1980-08-12 Akzona Incorporated Synthesis for the preparation of tetracyclic compounds
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
US4128641A (en) * 1975-07-31 1978-12-05 Hzi Research Center Inc. Tetracyclic psychotropic drug
NL7610942A (nl) * 1976-10-02 1978-04-04 Akzo Nv Werkwijze voor het bereiden van 1,4-diazepine derivaten.
NL7809726A (nl) * 1978-09-26 1980-03-28 Akzo Nv Nieuwe tetracyclische verbindingen.
DE3165289D1 (en) * 1980-12-31 1984-09-06 Beecham Group Plc Pentacyclic compounds, processes for their preparation and their use
EP0088575B1 (en) * 1982-03-05 1986-12-30 Beecham Group Plc Pentacyclic compounds
EP0090552A3 (en) * 1982-03-27 1984-04-25 Beecham Group Plc Pentacyclic compounds
EP0126343A1 (en) * 1983-05-18 1984-11-28 Beecham Group Plc Treatment of diarrhoea
DE3472678D1 (de) * 1983-07-18 1988-08-18 Beecham Group Plc Benzazepine and benzoxazepine derivatives
JP2865255B2 (ja) * 1987-04-10 1999-03-08 モナシュ ユニバーシティ １，２，３，４，１０，１４ｂ‐ヘキサヒドロジベンゾ〔ｃ，ｆ〕ピラジノ〔１，２‐ａ〕アゼピノ誘導体及び１０‐アザ，１０‐オキサ及び１０‐チア類似体
US5015738A (en) * 1989-08-07 1991-05-14 Hoechst-Roussel Pharmaceuticals Inc. Benzo(b)pyrrolobenzodiazepines
US5189161A (en) * 1989-08-07 1993-02-23 Hoechst Roussel Pharmaceuticals Inc. Benzo(b)pyrrolobenzodiazepines
DK0475482T3 (da) 1990-09-13 1995-04-03 Akzo Nobel Nv Stabiliserede faste kemiske midler
US5859012A (en) * 1996-04-03 1999-01-12 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
EP1017695A4 (en) * 1997-09-26 2002-01-16 Univ Monash RESOLUTION OF OPTICALLY ACTIVE COMPOUNDS
US6548522B1 (en) 1999-10-12 2003-04-15 Hoffmann-La Roche Inc. Method for treating conditions related to the glutamate receptor using carboxylic acid amide derivatives
US7355042B2 (en) * 2001-10-16 2008-04-08 Hypnion, Inc. Treatment of CNS disorders using CNS target modulators
US6723445B2 (en) 2001-12-31 2004-04-20 Canon Kabushiki Kaisha Organic light-emitting devices
ATE449633T1 (de) 2003-09-12 2009-12-15 Pfizer Kombinationen aus alpha-2-delta liganden und serotonin / noradrenalin-wiederaufnahmehemmern
MX2007006695A (es) 2004-12-03 2007-08-14 Schering Corp Piperazinas sustituidas como antagonistas de cb1.
NZ565683A (en) 2005-07-08 2011-04-29 Braincells Inc Methods for identifying agents and conditions that modulate neurogenesis in human neural cells
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
CN101355876B (zh) 2005-11-09 2012-09-05 康宾纳特克斯公司 一种适用于眼部给药的组合物
NZ569814A (en) 2006-01-18 2011-10-28 Schering Corp Cannibinoid receptor modulators
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
MX2008014320A (es) 2006-05-09 2009-03-25 Braincells Inc Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
US7858611B2 (en) * 2006-05-09 2010-12-28 Braincells Inc. Neurogenesis by modulating angiotensin
EP2021000A2 (en) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenesis by modulating angiotensin
EP2068872A1 (en) 2006-09-08 2009-06-17 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2008083204A2 (en) * 2006-12-28 2008-07-10 Braincells, Inc. Modulation of neurogenesis by melatoninergic ligands
CA2675132A1 (en) * 2007-01-11 2008-07-17 Braincells, Inc. Modulation of neurogenesis with use of modafinil
MX2010000334A (es) 2007-06-28 2010-04-22 Intervet Int Bv Piperazinas sustituidas como antagonistas de cannabinoides 1.
WO2009128058A1 (en) 2008-04-18 2009-10-22 UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al Psycho-pharmaceuticals
US9623000B2 (en) 2008-07-31 2017-04-18 Dekel Pharmaceuticals Ltd Compositions and methods for treating inflammatory disorders
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3004975A (en) * 1961-10-17 Cochs
US3005789A (en) * 1955-10-11 1961-10-24 Gen Aniline & Film Corp Drier composition
US3151116A (en) * 1961-11-03 1964-09-29 Ciba Geigy Corp Certain 2-aza-indolo [2, 3-alpha] quinolizine compounds
US3328396A (en) * 1961-11-09 1967-06-27 Sterling Drug Inc 3, 8-di-substituted-3, 8-diazabicyclo [3.2.1] octanes
US3196154A (en) * 1962-05-17 1965-07-20 Sterling Drug Inc 3-substituted-9-methyl-3, 9-diazabicyclo [3.3.1] nonanes
US3317524A (en) * 1965-02-04 1967-05-02 American Home Prod Substituted 1, 2, 3, 4-tetrahydro-pyrazino[1, 2-a]indoles
US3388128A (en) * 1965-09-03 1968-06-11 Allan R. Day Substituted 1, 4-diazabicyclo [4. 4. 9] decanes

Also Published As

Publication number Publication date
FR6764M (fi) 1969-03-10
FI51694B (fi) 1976-11-30
CH501647A (de) 1971-01-15
DE1695556A1 (de) 1972-01-20
NL6603256A (fi) 1967-09-13
BE695304A (fi) 1967-09-11
SE331999B (fi) 1971-01-25
DE1695556B2 (de) 1980-10-30
ES337526A1 (es) 1968-03-01
DE1795836C2 (de) 1978-07-20
DK124824B (da) 1972-11-27
GB1173783A (en) 1969-12-10
DE1695556C3 (de) 1981-06-25
BR6787719D0 (pt) 1973-12-26
GR37262B (el) 1969-05-10
DE1795836B1 (de) 1977-11-24
NL129434C (fi)
US3534041A (en) 1970-10-13

Similar Documents

Publication Publication Date Title
FI51694C (fi) Menetelmä uusien farmaseuttisesti arvokkaiden piperatsiinien ja niiden happoadditiosuolojen valmistamiseksi
FI48460C (fi) Menetelmä farmakologisesti vaikuttavien uusien amino-dihalogeenifenyyl ietyyliamiinien valmistamiseksi.
FI44912C (fi) Menetelmä alfa-karboksi-6-amino-penisillaanihappojohdannaisten ja niiden suolojen valmistamiseksi
AT294089B (de) Verfahren zur Herstellung von neuen Pyridinderivaten und therapeutisch verträglicher Salze hievon
FI47886C (fi) Menetelmä paikallispuudutusaineina käytettävien spiro-tetraliini-sukki ini-imidien N-alkyyliaminoalkyylijohdannaisten valmistamiseksi
FI48082C (fi) Menetelmä uusien verenpainetta alentavien 2-aryylihydratsino-imidatsol iinien-(2) valmistamiseksi
FI52076C (fi) Menetelmä trans-4-aminometyylisykloheksaani-1-karboksyylihapon ja 4-am inometyylibentsoehapon uusien terapeuttisesti vaikuttavien estereiden valmistamiseksi.
FI50409C (fi) Menetelmä pyridiini-karboksyylihappojen valmistamiseksi
FI47365C (fi) Menetelmä valmistaa uusia terapeuttisesti vaikuttavia indolijohdannais ia.
FI46154C (fi) Menetelmä terapeuttisesti käytettävien diaminobentsofenonien ja niiden happoadditiosuolojen valmistamiseksi.
FI45048C (fi) Menetelmä analgeettisesti ja/tai tulehduksenvastaisesti vaikuttavien a ntraniilihappojohdannaisten valmistamiseksi.
FI49408C (fi) Menetelmä terapeuttisesti käytettävien 1-fenoksimetyyli-3,4-dihydro- t ai 1,2,3,4-tetrahydroisokinoliinijohdannaisten ja niiden suolojen valm istamiseksi.
FI49612C (fi) Menetelmä farmakologisesti arvokkaitten aryylioksi-isoalkyyli-delta2-i midatsoliinijohdannaisten ja niiden happoadditiosuolojen valmistamisek si.
AT273909B (de) Verfahren zur Herstellung von neuen Diarylcyclopropanderivaten und deren Salzen
FI47881C (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen fenyyliasetamidi en valmistamiseksi
AT276409B (de) Verfahren zur Herstellung von neuen Pyrimidinderivaten und von deren Salzen
FI48733C (fi) Menetelmä kasvua edistävien ja kokkidiostaattisen vaikutuksen omaavien 4-hydroksi-3-kinoliini-karbonihappojohdannaisten ja niiden 1-substitu oitujen tautomeerien valmistamiseksi.
AT272346B (de) Verfahren zur Herstellung von neuen Chinolinderivaten und von deren Salzen
FI45045C (fi) Menetelmä uusien terapeuttisesti vaikuttavien 5-nitro-2-furyyli-isoksa tsolijohdannaisten valmistamiseksi.
FI46947C (fi) Aminoalkylideeni-substituoitujen 9,10-dihydroantraseenien ja näiden ha ppo-additiosuolojen valmistusmenetelmä
SE327405B (no) Förfarande för framställning av nya iminodibensylderivat
SE7602730L (sv) Nya derivat av penam-3-karboxylsyra och cefem-4-karboxylsyra
FI49033C (fi) Analogiamenetelmä kinolyyliformiminoeetterien ja niiden happoadditiosu olojen valmistamiseksi.
FI48458C (fi) Menetelmä terapeuttisesti arvokkaiden aminoalkyyli-substituoitujen ind aanien ja tetraliinien sekä näiden happo-additiosuolojen valmistamisek si.
FI49162C (fi) Menetelmä terapeuttisesti käytettävien 3-indolyyli-alifaattinen-happo- johdannaisten valmistamiseksi.